Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuma Fujimoto

Showing results (231-240 of 257) with videos related to

Pageof 26
Sort By:
Journal of Gastroenterology|December 16, 2014
Evidence-based clinical practice guidelines for irritable bowel syndromeShin Fukudo, Hiroshi Kaneko, Hirotada Akiho, et al.
Journal of Gastroenterology|November 28, 2012
Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levelsMasato Yoneda, Kento Imajo, Yuichiro Eguchi, et al.
Journal of Gastroenterology|November 3, 2010
The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver diseaseYuichiro Eguchi, Toshihiko Mizuta, Yoshio Sumida, et al.
Journal of Gastroenterology|December 17, 2022
Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter studyToshihiko Kakiuchi, Muneaki Matsuo, Hiroyoshi Endo, et al.
Journal of Gastroenterology|February 19, 2014
A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE studyKazunari Tominaga, Mototsugu Kato, Hiroshi Takeda, et al.
BMC Gastroenterology|May 3, 2012
Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS)Kouichi Sakurai, Akihito Nagahara, Kazuhiko Inoue, et al.
BMC Gastroenterology|July 4, 2014
Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshitoYasuhisa Sakata, Kazunari Tominaga, Mototsugu Kato, et al.
Journal of Gastroenterology|March 13, 2009
Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitisHiroaki Kusunoki, Masayasu Kusaka, Soichiro Kido, et al.
Digestion|February 7, 2018
Questionnaire-Based Survey on Gastrointestinal Bleeding and Management of Antithrombotic Agents during Endoscopy Among Asian CountriesNanae Tsuruoka, Ryuichi Iwakiri, Yasuhisa Sakata, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2020
Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)Toshihisa Takeuchi, Takahisa Furuta, Yasuhiro Fujiwara, et al.
Pageof 26

Showing results (231-240 of 257) with videos related to

Sort By:
Pageof 26
Journal of Gastroenterology|December 16, 2014
Evidence-based clinical practice guidelines for irritable bowel syndromeShin Fukudo, Hiroshi Kaneko, Hirotada Akiho, et al.
Journal of Gastroenterology|November 28, 2012
Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levelsMasato Yoneda, Kento Imajo, Yuichiro Eguchi, et al.
Journal of Gastroenterology|November 3, 2010
The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver diseaseYuichiro Eguchi, Toshihiko Mizuta, Yoshio Sumida, et al.
Journal of Gastroenterology|December 17, 2022
Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter studyToshihiko Kakiuchi, Muneaki Matsuo, Hiroyoshi Endo, et al.
Journal of Gastroenterology|February 19, 2014
A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE studyKazunari Tominaga, Mototsugu Kato, Hiroshi Takeda, et al.
BMC Gastroenterology|May 3, 2012
Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS)Kouichi Sakurai, Akihito Nagahara, Kazuhiko Inoue, et al.
BMC Gastroenterology|July 4, 2014
Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshitoYasuhisa Sakata, Kazunari Tominaga, Mototsugu Kato, et al.
Journal of Gastroenterology|March 13, 2009
Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitisHiroaki Kusunoki, Masayasu Kusaka, Soichiro Kido, et al.
Digestion|February 7, 2018
Questionnaire-Based Survey on Gastrointestinal Bleeding and Management of Antithrombotic Agents during Endoscopy Among Asian CountriesNanae Tsuruoka, Ryuichi Iwakiri, Yasuhisa Sakata, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2020
Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)Toshihisa Takeuchi, Takahisa Furuta, Yasuhiro Fujiwara, et al.
Pageof 26